Inhibition of skeletal muscle S1-myosin ATPase by peroxynitrite

Teresa Tiago1, Sónia Simão, Manuel Aureliano

  • 1Centre for Marine Sciences, Departamento de Química e Bioquímica, FCT, Universidade do Algarve 8005-139, Faro, Portugal.

Biochemistry
|March 15, 2006
PubMed

Insights

3-morpholinosydnonimine (SIN-1) inhibits myosin subfragment 1 (S1) ATPase activity by generating peroxynitrite, which oxidizes key cysteines near the catalytic site. This oxidation impairs S1

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Myosin subfragment 1 (S1) is crucial for muscle contraction, utilizing Mg(2+)-ATPase activity.
  • Oxidative stress can impact protein function, including key enzymes like S1.
  • 3-morpholinosydnonimine (SIN-1) is a known generator of peroxynitrite.

Purpose of the Study:

  • To investigate the inhibitory mechanism of SIN-1 on F-actin-stimulated S1 Mg(2+)-ATPase activity.
  • To determine if peroxynitrite is the active species responsible for inhibition.
  • To identify the specific molecular targets of SIN-1-induced modification in S1.

Main Methods:

  • Enzyme kinetics assays measuring S1 Mg(2+)-ATPase activity.
  • Treatment of S1 with SIN-1 and chemically synthesized peroxynitrite.
  • Use of enzyme scavengers like superoxide dismutase and catalase.
  • Cysteine titration with 5,5'-dithiobis(2-nitrobenzoic acid) and fluorescent labeling.
  • Differential scanning calorimetry (DSC) to assess protein stability.

Main Results:

  • SIN-1 time-dependently inhibited F-actin-stimulated S1 Mg(2+)-ATPase activity.
  • Inhibition was confirmed to be mediated by peroxynitrite generated from SIN-1.
  • Peroxynitrite oxidized reactive cysteines (Cys(707) and Cys(697)) near the S1 catalytic center.
  • SIN-1 treatment impaired the catalytic transition state and induced partial unfolding of S1.

Conclusions:

  • Peroxynitrite generated by SIN-1 is a potent inhibitor of S1 Mg(2+)-ATPase activity.
  • The primary mechanism involves oxidation of critical cysteine residues, affecting enzyme function.
  • SIN-1-induced modifications alter S1's structural integrity and catalytic efficiency.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...